📰 2 sources covering this story

Moderna shares nearly triple on skin cancer vaccine success

First covered 1 hrs ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Moderna shares nearly triple on skin cancer vaccine success
Moderna shares nearly triple on skin cancer vaccine success
Drugmaker’s melanoma shot developed with Merck delivers positive outcome in late-stage trial
The Times
The Times🏁 first to report1 hrs ago
Moderna shares jump 175% on skin cancer trial success
Moderna shares jump 175% on skin cancer trial success  The Times
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →